Physician profile
Tiffany Pan
NPI 1336434570
$3,093.20
in general payments reported to CMS, 2019-2025
11 companies · $226 in 2025
The $226 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,906 · 2020: $403 · 2021: $168 · 2022: $123 · 2023: $18.32 · 2024: $248 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $493.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $493.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $1,450.74 | 2019 | |
| Medartis INC. | $607.24 | 2019-2025 | Aptus |
| Pacira Therapeutics, INC. | $176.93 | 2019-2020 | |
| Stryker Corporation | $165.92 | 2019 | |
| Supreme Orthopedic Systems, LLC | $151.76 | 2025 | |
| Integra Lifesciences Corporation | $149.07 | 2022-2024 | Tenoglide |
| Depuy Synthes Sales INC. | $124.22 | 2019-2021 | |
| Smith+Nephew, INC. | $110.02 | 2022 | |
| Bioventus LLC | $106.13 | 2020 | |
| Checkpoint Surgical, INC | $31.03 | 2020-2023 | Checkpoint Stimulators |
| Amgen INC. | $20.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Pan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.